FMS

20.4401.54%
SJ

Shervin J. Korangy

CEO & Chairman of the Management Board

Mr. Shervin J. Korangy serves as Chief Executive Officer and Chairman of the Management Board at Fresenius Medical Care AG since October 12, 2026. He was President & CEO of BVI Medical, Inc. until January 2026. He is CEO & Member of Management Board of Fresenius Medical Care North America Holdings Limited Partnership from October 12, 2026. Mr. Korangy was Independent Member of Supervisory Board at Fresenius Medical Care AG since November 30, 2023 until October 12, 2026. He had been the President and Chief Executive Officer at Beaver-Visitec International, Inc. (BVI Medical) since May 2019 until February 2026 and also served as its Director until February 2026. He served as the President, Chief Executive Officer and Director of BVI Audley, Inc. He was the Chief Financial Officer and Chief Strategy Officer at Beaver-Visitec International, Inc. from April 10, 2017 to May 2019 and also served as its Head of Strategy from April 2017 to May 2019. He has general management, operational, financial and investment experience across a diverse array of industries including healthcare, consumer products, industrial manufacturing and financial services. Mr. Korangy has experience leading capital allocation, strategic growth and operational initiatives for companies across a wide range of industries including the healthcare, financial services and consumer products sectors. He served as Global Head of Corporate Finance at Novartis, overseeing M&A and Integrations, as well as in general management in multiple countries, overseeing medical device, pharmaceutical and consumer health product segments for the Alcon division of Novartis. He served as Principal of Private Equity group and Managing Director of Restructuring & Reorganization Advisory Group and Principal at The Blackstone Group LP. Since joining Blackstone in 1996, he involved in advising debtors and creditors in various transactions, including AT&T in the restructuring of Excite@Home, Anacomp, Inc., Best Products Co., Inc., The Caldor Corporation, Camelot Music, Inc., Ermis Maritime Holdings, JPS Textile Group, Inc., Motorola in the restructuring of Iridium, Paragon Trade Brands, Plaid Clothing Group, Inc., Safelite Glass Corp., SLM International, Inc., Stokely USA, Inc., Supercanal Holding S. A., Vencor Inc., Wherehouse Entertainment and Winstar Communications, Inc. He served as senior executive of Novartis Group AG. He served as Vice President of Pinnacle Foods Inc. (Also known as Pinnacle Foods Finance LLC) until March 2009. He also spent a year at Gleacher and Company working on Mergers & Acquisitions transactions and various venture capital investments. He has been a Director of MOTUS GI Medical Technologies Ltd. since May 17, 2017. He was Independent Director at Motus GI Holdings Inc since March 2017 until July 14, 2023. He had been a Director at The Hain Celestial Group, Inc. since September 27, 2017 until October 09, 2026 and a senior advisor to Sight Sciences LLC. He serves as a Director of Pelican Rouge BV. He served as a Director of Pinnacle Foods Inc. from 2014 to 2017. He served as Director of Bayview Financial from 2007 to 2009. He was Director of Ultra Music from 2008 to 2009. He served as Board observer for Graham Packaging from 2005 to 2010. Mr. Korangy has served on the Wharton Undergraduate Executive Board since 2024. Mr. Korangy has also served on the Wharton Leadership Advisory Board, established by the Center for Leadership and Change Management at The Wharton School of the University of Pennsylvania, since January 2019. Mr. Korangy received a BS in Economics with concentrations in Finance and Entrepreneurial Management from The Wharton School of the University of Pennsylvania, where he graduated with high honors.

Positions